About
Generics
Areas of Focus
Categories
Generic DrugOther European
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
0
As Collaborator
2
Total Enrollment
197
By Phase
PHASE1/PHASE2: 1PHASE1: 1
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT04734548Collaborator
Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke
PHASE1/PHASE2Completed
151 participants
Started: Oct 28, 2020 · Completed: Sep 7, 2022
NCT04742062Collaborator
First in Human Clinical Trial of ApTOLL in Healthy Volunteers
PHASE1Completed
46 participants
Started: Jul 18, 2019 · Completed: Mar 20, 2020
Locations (1)
Headquarters
Athens, Greece
Map
Loading map...